PRIME Centre Wales
Long Term Conditions Consensus Meeting
Tuesday 10th November 2015, St Mary's Priory, Abergavenny, NP7 5ND
http://www.primecentre.wales/ltc-consensus-meeting.php
PRIME Centre Wales
Long Term Conditions Consensus Meeting
Tuesday 10th November 2015, St Mary's Priory, Abergavenny, NP7 5ND
http://www.primecentre.wales/ltc-consensus-meeting.php
Patients at the Centre for Health Research – Patient, Carer and Public Invol...Nowgen
"Patients at the Centre for Health Research –
Patient, Carer and Public Involvement in NICE Decision-Making", presented by Victoria Thomas, NICE, at the EUPATI-UK Network Conference on 6 March 2014 in Leeds, UK
Professor Justin Waring - Implementing evidence and improvementCLAHRC-NDL
Professsor Justin Waring presentation on Implementing evidence and improvement, delivered at NIHR CLAHRC East Midlands launch event on 14 February 2014, Loughborough.
Professsor John Gladman - Caring for older people and stroke survivorsCLAHRC-NDL
Caring for older people and stroke survivors theme presentation by Professor John Gladman, delivered at the NIHR CLAHRC East Midlands launch event on 14 February 2014, Loughborough.
PRIME Centre Wales
Long Term Conditions Consensus Meeting
Tuesday 10th November 2015, St Mary's Priory, Abergavenny, NP7 5ND
http://www.primecentre.wales/ltc-consensus-meeting.php
Patients at the Centre for Health Research – Patient, Carer and Public Invol...Nowgen
"Patients at the Centre for Health Research –
Patient, Carer and Public Involvement in NICE Decision-Making", presented by Victoria Thomas, NICE, at the EUPATI-UK Network Conference on 6 March 2014 in Leeds, UK
Professor Justin Waring - Implementing evidence and improvementCLAHRC-NDL
Professsor Justin Waring presentation on Implementing evidence and improvement, delivered at NIHR CLAHRC East Midlands launch event on 14 February 2014, Loughborough.
Professsor John Gladman - Caring for older people and stroke survivorsCLAHRC-NDL
Caring for older people and stroke survivors theme presentation by Professor John Gladman, delivered at the NIHR CLAHRC East Midlands launch event on 14 February 2014, Loughborough.
Professor Richard Morriss - Enhancing Mental HealthCLAHRC-NDL
Presentation on Enhancing Mental Health theme research, by Professor Richard Morriss at the NIHR CLAHRC East Midlands launch event, 14 February 2014, Loughborough.
Professor Kamlesh Khunti - Prevention of Chronic DiseaseCLAHRC-NDL
Presentation by Professor Kamlesh Khunti on Prevention of Chronic Disease. Professor Khunti is Director of NIHR CLAHRC East Midlands and leads the Preventing Chronic Disease research theme.
Apresentação realizada no I Seminário Internacional de Atenção às Condições Crônicas, pela diretora do Programa da Gestão de Doenças Crônica dos Serviços Sanitários De Alberta/Canadá, Sandra Delon.
Belo Horizonte, 11 de novembro de 2014
his is the first in a series of interactive webinars designed to build capacity in the basic principles of knowledge translation and implementation science.
WATCH-ON DEMAND: https://goo.gl/hnp8gi
Professor Kamlesh Khunti - Introduction to CLAHRC East MidlandsCLAHRC-NDL
Professor Kamlesh Khunti, Director of NIHR CLAHRC East Midlands - Introductory presentation given at CLAHRC East Midlands launch event, 14 February 2014, Loughborough.
Patient involvement in medicines development – the views of patients and key ...Nowgen
"EUPATI – EU: An overview", held by Bella Starling & Suzanne Parsons (EUPATI / Nowgen) at the EUPATI-UK Network Conference on 6 March 2014 in Leeds, UK
New technological trends in nursing uqu oct2015gracegrace lindsay
This presentation provides a short historical overview of the evolving use of technology in nursing practice by means of an introduction to the topic. A review is then presented on the latest classes of devices in use in healthcare delivery (with examples), their supporting communication systems and considerations of their strengths and limitations. A key meesage to the healthcare sector is that this technological advancement is speeding ahead of policy, procedural and infrastuctural considerations. The personal use of devices has become embedded in practice leading to random and unregulated use and limited attention to codes of safe practice and recommended standards of care.
AHRQ pbrn webinar electronic health record functionality needed to better sup...Vince Pereira, MHA
Feb 28, 2014 presentation by AHRQ - "Electronic health record functionality needed to better support primary care: Joint Statement AAFP, AAP, ABFM, and NAPCRG"
Magnus Liungman: RCTs in complex settings Nuffield Trust
Magnus Liungman and Dr Gustaf Edgren present on the lessons learned from developing a healthcare prevention intervention for frequent emergency department visitors.
Patient Engagement Presentation - MPN Network Forum April 18, 2017Alexandra Enns
April 18, 2017
In April we held a Network Forum on engaging policymakers and patients/public effectively and appropriately. We would like to give a warm thanks to both Carolyn Shimmin, Patient Engagement expert of CHI's Knowledge Translation team, and Marcia Thomson, Assistant Deputy Minister of Manitoba Health, Seniors and Active Living for their presentations. Below you can see Carolyn's presentation - to see more of her work on patient engagement and to learn more about knowledge translation at CHI, please check out the blog Knowledge Nudge here. If you would like more information, helpful tools or advice about patient/public engagement in research, please contact Carolyn Shimmin at cshimmin@exchange.hsc.mb.ca
NHS Improving Quality and NHS England are working nationally with the Academic Health Science Networks to provide support and opportunities for the Collaboratives to learn from each other, ensuring the most effective and successful solutions are rapidly spread and adopted across England.
For the next five years, each Collaborative will support individuals, teams and organisations to build skills and knowledge about patient safety and quality improvement to create space and time to work on the challenges, and provide opportunities to learn from each other.
The programme is borne out of Professor Don Berwick's report last year into the safety of patients in England and builds on learning from the Francis and Winterbourne View recommendations. The report, A Promise to Learn - a commitment to act, made a series of recommendations to improve patient safety; and called for the NHS ''to become, more than ever before, a system devoted to continual learning and improvement of patient care, top to bottom and end to end.'
Aligned with and supporting the 'Sign up to Safety' campaign, the programme aims to make the NHS the safest healthcare system in the world by creating the culture to support a system devoted to continuous learning and improvement.
This resource summarises the Patient Safety Collaboratives current priority plans. Some of these plans are in consultation with partner organisations and may be subject to change. - See more at: http://www.nhsiq.nhs.uk/resource-search/publications/safety-collaborative-plans.aspx#sthash.O5lUFIQf.dpuf
Geneva Pharma Forum on Pharmacovigilance: Partnering for
Patient Safety (Geneva, 20 November 2012), Jeremiah Mwangi, Director, Policy and External Affairs, IAPO
Professor Richard Morriss - Enhancing Mental HealthCLAHRC-NDL
Presentation on Enhancing Mental Health theme research, by Professor Richard Morriss at the NIHR CLAHRC East Midlands launch event, 14 February 2014, Loughborough.
Professor Kamlesh Khunti - Prevention of Chronic DiseaseCLAHRC-NDL
Presentation by Professor Kamlesh Khunti on Prevention of Chronic Disease. Professor Khunti is Director of NIHR CLAHRC East Midlands and leads the Preventing Chronic Disease research theme.
Apresentação realizada no I Seminário Internacional de Atenção às Condições Crônicas, pela diretora do Programa da Gestão de Doenças Crônica dos Serviços Sanitários De Alberta/Canadá, Sandra Delon.
Belo Horizonte, 11 de novembro de 2014
his is the first in a series of interactive webinars designed to build capacity in the basic principles of knowledge translation and implementation science.
WATCH-ON DEMAND: https://goo.gl/hnp8gi
Professor Kamlesh Khunti - Introduction to CLAHRC East MidlandsCLAHRC-NDL
Professor Kamlesh Khunti, Director of NIHR CLAHRC East Midlands - Introductory presentation given at CLAHRC East Midlands launch event, 14 February 2014, Loughborough.
Patient involvement in medicines development – the views of patients and key ...Nowgen
"EUPATI – EU: An overview", held by Bella Starling & Suzanne Parsons (EUPATI / Nowgen) at the EUPATI-UK Network Conference on 6 March 2014 in Leeds, UK
New technological trends in nursing uqu oct2015gracegrace lindsay
This presentation provides a short historical overview of the evolving use of technology in nursing practice by means of an introduction to the topic. A review is then presented on the latest classes of devices in use in healthcare delivery (with examples), their supporting communication systems and considerations of their strengths and limitations. A key meesage to the healthcare sector is that this technological advancement is speeding ahead of policy, procedural and infrastuctural considerations. The personal use of devices has become embedded in practice leading to random and unregulated use and limited attention to codes of safe practice and recommended standards of care.
AHRQ pbrn webinar electronic health record functionality needed to better sup...Vince Pereira, MHA
Feb 28, 2014 presentation by AHRQ - "Electronic health record functionality needed to better support primary care: Joint Statement AAFP, AAP, ABFM, and NAPCRG"
Magnus Liungman: RCTs in complex settings Nuffield Trust
Magnus Liungman and Dr Gustaf Edgren present on the lessons learned from developing a healthcare prevention intervention for frequent emergency department visitors.
Patient Engagement Presentation - MPN Network Forum April 18, 2017Alexandra Enns
April 18, 2017
In April we held a Network Forum on engaging policymakers and patients/public effectively and appropriately. We would like to give a warm thanks to both Carolyn Shimmin, Patient Engagement expert of CHI's Knowledge Translation team, and Marcia Thomson, Assistant Deputy Minister of Manitoba Health, Seniors and Active Living for their presentations. Below you can see Carolyn's presentation - to see more of her work on patient engagement and to learn more about knowledge translation at CHI, please check out the blog Knowledge Nudge here. If you would like more information, helpful tools or advice about patient/public engagement in research, please contact Carolyn Shimmin at cshimmin@exchange.hsc.mb.ca
NHS Improving Quality and NHS England are working nationally with the Academic Health Science Networks to provide support and opportunities for the Collaboratives to learn from each other, ensuring the most effective and successful solutions are rapidly spread and adopted across England.
For the next five years, each Collaborative will support individuals, teams and organisations to build skills and knowledge about patient safety and quality improvement to create space and time to work on the challenges, and provide opportunities to learn from each other.
The programme is borne out of Professor Don Berwick's report last year into the safety of patients in England and builds on learning from the Francis and Winterbourne View recommendations. The report, A Promise to Learn - a commitment to act, made a series of recommendations to improve patient safety; and called for the NHS ''to become, more than ever before, a system devoted to continual learning and improvement of patient care, top to bottom and end to end.'
Aligned with and supporting the 'Sign up to Safety' campaign, the programme aims to make the NHS the safest healthcare system in the world by creating the culture to support a system devoted to continuous learning and improvement.
This resource summarises the Patient Safety Collaboratives current priority plans. Some of these plans are in consultation with partner organisations and may be subject to change. - See more at: http://www.nhsiq.nhs.uk/resource-search/publications/safety-collaborative-plans.aspx#sthash.O5lUFIQf.dpuf
Geneva Pharma Forum on Pharmacovigilance: Partnering for
Patient Safety (Geneva, 20 November 2012), Jeremiah Mwangi, Director, Policy and External Affairs, IAPO
The UK is at the forefront of the global pharmaceutical industry. As well as developing new medicines for many diseases, the pharmaceutical industry in the UK provides many other benefits to the British economy, including income, employment, expertise and major investment.
Co-ordinated malaria research for better policy and practice: the role of res...ACT Consortium
Prof. David Schellenberg from the London School of Hygiene & Tropical Medicine presents on behalf of the ACT Consortium at the European Congress on Tropical Medicine and International Health in Basel, Switzerland, 8 September 2015
Patient involvement in clinical research and long term conditions -what can b...Nowgen
"Patient involvement in clinical research and long term conditions -what can be achieved by working in partnership", presented by Dr. J. Paul Schofield, ABPI, at EUPATI-UK Network Conference on 6 March 2014 in Leeds, UK
Presentation: Global pharmacovigilance networks - A regulator'sTGA Australia
Global pharmaceutical companies manufacture and distribute a broad portfolio of drug products in multiples regions and countries. The pharmacovigilance system must ensure safety data collection in compliance with local regulations, and consolidate all sources to ensure an ongoing monitoring of potential changes in benefit-risk profiles. It must also guarantee a timely communication to patients, prescribers and regulatory authorities. The complexity resides in the need for a dense network of local safety departments, a strong global organisation processing and analysing cases, and a reporting system ensuring compliance to heterogeneous regulatory requirements. Pfizer has one of the largest pharmacovigilance department among all global companies, and has established patient safety as a core priority. We will describe how pharmacovigilance is organised at Pfizer, global compliance and individual patient safety.
Karen Livingstone - ECO 17: Transforming care through digital healthInnovation Agency
Presentation by Karen Livingstone, Director of Innovation Exchange and SBRI Healthcare, NHS England: Transforming Health and Social Care Services - The Innovation Exchange and SBRI Healthcare at ECO 17: Transforming care through digital health on Tuesday 4 December at Lancaster University, Lancaster
“National Patient Safety Collaborative Programme”
The National Patient Safety Collaborative Programme, launched on the 14th October 2014 will be the largest patient safety initiative ever attempted in the world. Led by the 15 Academic Health Science Networks and supported by NHS England and NHS Improving Quality, they will be undertaking a challenging programme of work over the next 5 years. This session will outline the actions to date and the next steps moving forwards.
Tripartite dimension of interaction of patients, regulators and industry (Jan...jangeissler
Tripartite dimension of interaction of patients, regulators and industry, presented by Jan Geissler as a scene-setting presentation at the EUPATI Workshop on the interaction of patients, regulators and industry on 20 July 2016 in Berlin
Similar to Richard Neal LTC _Consensus Meeting 10-Nov-2015 (20)
PRIME Centre Wales
Long Term Conditions Consensus Meeting
Tuesday 10th November 2015, St Mary's Priory, Abergavenny, NP7 5ND
http://www.primecentre.wales/ltc-consensus-meeting.php
PRIME Centre Wales
Long Term Conditions Consensus Meeting
Tuesday 10th November 2015, St Mary's Priory, Abergavenny, NP7 5ND
http://www.primecentre.wales/ltc-consensus-meeting.php
Age Alliances Wales_LTC Consensus Meeting 10-Nov-2015angewatkins
PRIME Centre Wales
Long Term Conditions Consensus Meeting
Tuesday 10th November 2015, St Mary's Priory, Abergavenny, NP7 5ND
http://www.primecentre.wales/ltc-consensus-meeting.php
Dan Venables_LTC Consensus Meeting 10-Nov-2015angewatkins
PRIME Centre Wales
Long Term Conditions Consensus Meeting
Tuesday 10th November 2015, St Mary's Priory, Abergavenny, NP7 5ND
http://www.primecentre.wales/ltc-consensus-meeting.php
Pace study training slides 22 09-2015 v2.1angewatkins
Primary care use of a C-Reactive Protein (CRP) Point of Care Test (POCT) to help target antibiotic prescribing to patients with Acute Exacerbations of Chronic Obstructive Pulmonary Disease (AECOPD) who are most likely to benefit.
Cardiff University Healthy Ageing Conference & Public Lecture
The importance of a healthy lifestyle
A Conference and a Public Lecture
Thursday 30th October 2014
http://medicine.cardiff.ac.uk/event/healthy-ageing-conference-public-lecture/
Cardiff University Healthy Ageing Conference & Public Lecture
The importance of a healthy lifestyle
A Conference and a Public Lecture
Thursday 30th October 2014
http://medicine.cardiff.ac.uk/event/healthy-ageing-conference-public-lecture/
Cardiff University Healthy Ageing Conference & Public Lecture
The importance of a healthy lifestyle
A Conference and a Public Lecture
Thursday 30th October 2014
http://medicine.cardiff.ac.uk/event/healthy-ageing-conference-public-lecture/
263778731218 Abortion Clinic /Pills In Harare ,sisternakatoto
263778731218 Abortion Clinic /Pills In Harare ,ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group of receptionists, nurses, and physicians have worked together as a teamof receptionists, nurses, and physicians have worked together as a team wwww.lisywomensclinic.co.za/
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
Basavarajeeyam is a Sreshta Sangraha grantha (Compiled book ), written by Neelkanta kotturu Basavaraja Virachita. It contains 25 Prakaranas, First 24 Chapters related to Rogas& 25th to Rasadravyas.
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
1. PRIME Centre Wales
Working with Industry
Prof Richard Neal
North Wales Centre for Primary Care
Research
Bangor University
2. One of our key outputs:
• Collaboration with industry and 3rd sector: Increase number of
commercial and 3rd
sector partners in current portfolio over award
period (2015-18) and >= four themes to win research funding
(>£250k) in collaboration with enterprise and innovation colleagues
across Wales
• Hence, PRIME Centre Wales will continue to work closely with Health
Research Wales, and is committed to undertake work with
commercial partners in primary, community and emergency settings
3. PRIME is open for business with industry
• Equipment designed for patients in secondary care not always
suitable for use in the community – need for compact innovations
• Multi-disciplinarity of PRIME
• Access to large population
4. Examples of current work with industry - Long Term
Conditions and Co-morbidity
• Currently working in collaboration with Motek Medical partnership on
the recently installed GRAIL system prototype protocol for
assessment and treatment of knee conditions
• The Healthy Eating and Lifestyle in Pregnancy (MRC/HPPI funded)
trial is working with Slimming World to deliver a weight loss
intervention
• The Helpmedoit study is a web and text based intervention to
facilitate social support for health related behaviour change and has
an industry partner ‘Healthcare Learning Smile-on’. Smile–on will
advise on and develop the platform and programming for the delivery
of the intervention, as well as provide ongoing support and
maintenance. We have worked successfully with this company on a
number of projects (including the STAR study)
5. Examples of current work with industry – Other Work
Packages
Patient-Centred and Prudent Healthcare
•We are currently developing online training for clinicians treating older
women with breast cancer in collaboration with Smile-on. This is to
disseminate training in shared decision-making and use of Option Grid
decision aids, booklets and individualised risk assessment to 40 breast
centres around UK (NIHR programme grant)
6. Examples of current work with industry – Other Work
Packages
Infections and Antimicrobial Resistance
•Key players in the €11M EU IMI funded RAPP-ID ‘Development of
RApid Point-of-Care Test Platforms for Infectious Diseases’ project.
This is a public-private partnership between the EU and EFPIA
(GlaxoSmithKline, Johnson & Johnson, Novartis, Sanofi-Aventis,
Merck) 10 Universities and 5 SMEs across Europe)
7. Examples of current work with industry – Other Work
Packages
Screening, Prevention and Diagnosis in Primary Care
•A study in collaboration with Philips, evaluating the use of self-testing
of blood in rural patients undergoing chemotherapy is in progress. We
are planning trials of interventions of candidate biomarkers in cancer
diagnosis in primary care which will involve close collaboration with
industry
8. Examples of current work with industry – Other Work
Packages
Unscheduled and Emergency (includes pre-hospital) Care
•We are working in partnership with software providers Plain
Healthcare, Medusa Medical Technologies and Ortivus on the Support
and Assessment for Fall Emergency Referral trial. We will continue this
work through a trial of computerised clinical decision support for
paramedics in the care of 999 patients without life threatening
conditions, using anonymised linked data recruitment and outcomes
9. Examples of current work with industry – Other Work
Packages
Patient Safety
•The NIHR PISA Study is producing a primary care-specific patient
safety incident classification system to describe the characteristics,
causes, and severity of harm and outcomes of patient safety incidents
in primary care. DATIX, the world leading provider of patient safety
incidents software, has expressed interest in testing and validating the
classification for inclusion in their software
10. Examples of current work with industry – Other Work
Packages
Patient Safety
•The NIHR PISA Study is producing a primary care-specific patient
safety incident classification system to describe the characteristics,
causes, and severity of harm and outcomes of patient safety incidents
in primary care. DATIX, the world leading provider of patient safety
incidents software, has expressed interest in testing and validating the
classification for inclusion in their software